Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies

BACKGROUND: Liquid rebiopsies can detect resistance mutations to guide therapy of anaplastic lymphoma kinase-rearranged (ALK(+)) non-small-cell lung cancer (NSCLC) failing tyrosine kinase inhibitors (TKI). Here, we analyze how their results relate to the anatomical pattern of disease progression and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Lung Cancer Res
Autors principals: Christopoulos, Petros, Dietz, Steffen, Angeles, Arlou K., Rheinheimer, Stephan, Kazdal, Daniel, Volckmar, Anna-Lena, Janke, Florian, Endris, Volker, Meister, Michael, Kriegsmann, Mark, Zemojtel, Thomasz, Reck, Martin, Stenzinger, Albrecht, Thomas, Michael, Sültmann, Holger
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8182700/
https://ncbi.nlm.nih.gov/pubmed/34164264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-21-32
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars